相似文献
1
McKesson settling up. $190 million payment latest in drug-price flap.
Mod Healthc. 2012 Apr 30;42(18):14.
2
The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541.
3
US lawmakers seek cuts in prescription drug prices.
Lancet. 2019 Mar 9;393(10175):975-976. doi: 10.1016/S0140-6736(19)30537-9.
4
PhRMA sues on 340B orphans.
Mod Healthc. 2013 Oct 7;43(40):17.
5
An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
JAMA. 2018 Jun 19;319(23):2373-2374. doi: 10.1001/jama.2018.7424.
6
Remember the MaineRx.
Appl Health Econ Health Policy. 2014 Feb;12(1):1-5. doi: 10.1007/s40258-013-0076-3.
7
Pharmaceuticals and medical devices: business practices.
Issue Brief Health Policy Track Serv. 2014 Dec 29:1-38.
8
Opinion: price controls on prescription drugs.
N J Med. 2004 Apr;101(4):56, 55.
9
Can price and regulatory controls replace free market competition in the drug industry?
Healthspan. 1993 Nov;10(10):30-2.
10
Enforcement actions involving Medicaid fraud and abuse, 1996-2009.
Arch Intern Med. 2011 Apr 25;171(8):785-7. doi: 10.1001/archinternmed.2011.142.
Zotero 插件